克洛扎延迟对精神分裂症临床结果的影响
Claire Law1, Yuen Mei See2, Jie Yin Yee2
1Department of Forensic Psychiatry, Institute of Mental Health, Singapore.
The Journal of clinical psychiatry
|August 24, 2023
概括
对治疗耐药精神分裂症 (TRS) 启动克洛扎宾的延迟是常见的,可能会使患者的结果恶化. 较早的克洛扎宾治疗与精神分裂症患者的更好的症状和功能性缓解率有关.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 克洛扎是治疗耐药精神分裂症 (TRS) 的黄金标准治疗方法.
- 克洛扎开始和使用不足的延迟可能会损害其临床有效性.
- 了解延迟开服克洛扎对患者结果的影响至关重要.
研究的目的:
- 为了研究接受克洛扎治疗的患者的临床结果.
- 为了确定延迟克洛沙平的开始是否与较差的治疗结果有关.
- 分析先前抗精神病药物试验与克洛札疗效之间的关系.
主要方法:
- 一项队列研究在一所高等精神卫生机构进行.
- 评估了159名被诊断患有精神分裂症或精神分裂情绪障碍的患者.
- 标准化尺度 (PANSS,SOFAS) 和临床面试 (SCID-I) 用于评估症状和功能.
主要成果:
- 观察到克洛扎开始的显著延迟,这与TRS指南相反.
- 23.3%的患者实现了症状缓解,63.5%实现了功能缓解.
- 在开始使用克洛扎之前,较少的抗精神病试验与症状和功能缓解显著相关.
结论:
- 在TRS患者中,克洛扎平的延迟开始是普遍的,可能会对临床结果产生负面影响.
- 较早开始使用克洛扎宾与改善症状和功能缓解的机会有关.
- 需要进一步的研究来阐明克洛扎延迟的后果,并改善患者的接入.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
165
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
165
01:29Psychological and Sociocultural Causes of Schizophrenia
138
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
138
01:28Psychosis and Antipsychotic Drugs: Overview
327
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
327
01:28Drug Therapy
68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
68
01:21Antipsychotic Drugs: Typical and Atypical Agents
246
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
246
01:17Schizophrenia
137
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
137